T he prevalence of type 2 diabetes mellitus has increased dramatically in the past decades, and the disease now affects approximately 8% of U.S. adults (1) . Diet and lifestyle factors are primary determinants of risk for type 2 diabetes (2) . In addition to overweight and obesity, other independent behavioral and lifestyle factors include physical inactivity, smoking, and a diet higher in glycemic load and trans fatty acids and lower in fiber and polyunsaturated fatty acids. Coffee consumption may be related to diabetes because short-term metabolic studies have suggested that caffeine adversely affects insulin sensitivity and glucose metabolism (3) . Coffee consumption is widespread; more than 50% of Americans drink coffee, and average per capita intake is about 2 cups per day (4) . Coffee is the primary source of caffeine intake, providing approximately 210 mg/d per person in the United States.
In humans, acute administration of caffeine decreases insulin sensitivity and impairs glucose tolerance (3, (5) (6) (7) (8) .
On the other hand, caffeine stimulates thermogenesis and increases energy expenditure (9 -11), which may facilitate weight reduction and maintenance. Because of these complex physiologic effects of caffeine and because tolerance to the humoral and hemodynamic effects of caffeine typically develops with long-term use (12) , it is difficult to extrapolate findings from short-term metabolic studies to longterm use of coffee and other caffeinated beverages.
A recent epidemiologic study has found a statistically significant inverse association between coffee consumption and risk for type 2 diabetes in a sample of Dutch participants (13). After adjustment for potential confounders, the relative risk for type 2 diabetes among participants consuming at least 7 cups of coffee per day as compared with those consuming 2 cups or less per day was 0.50 (95% CI, 0.35 to 0.72; P Ͻ 0.001 for trend). The study, however, could not distinguish regular coffee from decaffeinated coffee and did not evaluate the association with total caffeine intake.
In our study, we examined long-term intake of coffee and other caffeinated beverages and decaffeinated coffee in relation to incidence of type 2 diabetes in 2 large prospective cohorts of men and women. In particular, we examined whether the associations were modified by smoking and body mass index.
METHODS

Study Sample The Health Professionals Follow-up Study
The Health Professionals Follow-up Study (HPFS) was established in 1986 when 51 529 male health professionals, including dentists, optometrists, veterinarians, osteopathic physicians, podiatrists, and pharmacists, who were 40 to 75 years of age returned a mailed questionnaire providing detailed information about their medical history, lifestyle, and other risk factors (14) . Information on the cohort is updated every 2 years to identify newly diagnosed diseases. For our analysis, we excluded men with a previous diagnosis of type 2 diabetes, coronary heart disease, or cancer at baseline. Participants who did not complete more than 70 of 131 food items in the 1986 dietary questionnaire or had extreme scores for total daily intake of energy (Ͻ800 kcal or Ͼ4200 kcal) were excluded. After exclu-sions, the analysis included 41 934 eligible men who were followed from 1986 to 1998.
The Nurses' Health Study
The Nurses' Health Study (NHS) was established in 1976 when 121 700 female nurses 30 to 55 years of age living in 11 large states completed a mailed questionnaire providing detailed information about their medical history, lifestyles, and other risk factors (15) . The information is updated every 2 years to identify newly diagnosed diseases. In 1980, a semiquantitative food frequency questionnaire was added. For our analysis, we excluded women with a previous diagnosis of type 2 diabetes, coronary heart disease, or cancer at baseline. Participants who did not complete more than 10 items on the 1980 dietary questionnaire or had extreme scores for total daily intake of energy (Ͻ500 kcal or Ͼ3500 kcal) were also excluded, leaving 84 276 eligible women who were followed from 1980 to 1998.
Assessment of Coffee and Caffeine Intake
Validated dietary questionnaires were sent to the HPFS participants in 1986, 1990, and 1994 and to the NHS participants in 1980, 1984, 1986, 1990, and 1994 . In all the questionnaires, participants were asked how often on average during the previous year they had consumed coffee and tea. Decaffeinated coffee and different types of caffeinated soft drinks were first assessed in 1986 in the HPFS and in 1984 in the NHS. We assessed the total intake of caffeine by summing the caffeine content for a specific amount of each food during the previous year (1 cup for coffee or tea, one 12-ounce bottle or can for carbonated beverages, and 1 ounce for chocolate) multiplied by a weight proportional to the frequency of its use. The participants could choose from 9 frequency responses (never, 1 to 3 per month, 1 per week, 2 to 4 per week, 5 to 6 per week, 1 per day, 2 to 3 per day, 4 to 5 per day, and 6 or more per day). Using the U.S. Department of Agriculture food composition sources, we estimated that the caffeine content was 137 mg per cup of coffee, 47 mg per cup of tea, 46 mg per bottle or can of cola beverage, and 7 mg per serving of chocolate candy. In our validation studies, high correlations were recorded for coffee and other caffeinated beverage intake assessed by the food frequency questionnaire and several 1-week diet records (coffee, r ϭ 0.78; tea, r ϭ 0.93; and caffeinated sodas, r ϭ 0.85) (16) .
For these analyses, coffee consumption was categorized into 5 groups: never, less than 1 cup per day, 1 to 3 cups per day, 4 to 5 cups per day, and 6 cups or more per day. Caffeine intake was categorized into quintiles.
Assessment of Diabetes Cases
Participants who reported having diabetes were sent a supplementary mailed questionnaire that asked about symptoms, diagnostic tests, and treatment. We considered any 1 of the following criteria to represent a new case of diabetes: classic symptoms and elevated glucose levels (fasting plasma glucose concentration Ն 7.8 mmol/L [Ն140 mg/dL] or randomly measured concentration Ն 11.1 mmol/L [Ն200 mg/dL]); at least 2 elevated plasma glucose concentrations on different occasions in the absence of symptoms (plasma glucose level Ն 11.1 mmol/L [Ն200 mg/dL] 2 or more hours after oral glucose tolerance testing); or treatment with oral hypoglycemic agents or insulin. Our criteria for diabetes classification are consistent with those proposed by the National Diabetes Data Group (17) because most cases were diagnosed before 1997.
The validity of this diagnostic procedure has been verified in a subsample of this study sample (18) . The diagnosis of type 2 diabetes was confirmed by medical records in 98% of the participants. In addition, another substudy assessing the prevalence of undiagnosed diabetes suggested a very low rate of false-negative results (19).
Statistical Analysis
We calculated the follow-up period from the return of the baseline questionnaires (in 1986 for men and in 1980 for women) to the diagnosis of type 2 diabetes, death, or the end of follow-up (January 1998 for men and June 1998 for women), whichever occurred first.
Incidence rates for diabetes were calculated by dividing incident cases by person-years of follow-up in each category of coffee intake. Relative risks were calculated as the rate of occurrence of type 2 diabetes in each quintile of caffeine intake divided by the corresponding rate in the lowest quintile, and 95% CIs were calculated. To inspect potential confounding variables for the analyses, we examined baseline characteristics (directly standardized to the age distribution of each cohort) according to coffee consumption levels. We used proportional hazards models (20) to adjust for several risk factors, including age in 5 categories (Ͻ50, 50 to 54, 55 to 59, 60 to 64, or Ն65
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A recently published study in a Dutch population identified an association between higher coffee consumption and lower risk for type 2 diabetes mellitus but did not distinguish between intake of regular and decaffeinated coffee.
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Article ; alcohol consumption (0, 0.1 to 4.9, 5 to 9.9, 10 to 14.9, or Ն15 g/d); total calorie intake (continuous); and quintiles of trans fat, glycemic load, and cereal fiber intake. We also adjusted for magnesium intake because our previous analyses have shown an inverse association between dietary magnesium and risk for diabetes (21) . Information on covariates was updated periodically during follow-up. We performed a test for trend by treating median values of each category of caffeine and coffee intake as continuous variables.
To represent long-term intake of coffee and caffeine and to reduce measurement error, we conducted analyses using cumulative updated caffeine and coffee intake from all questionnaires (22) . For example, in the NHS, diabetes incidence between 1980 and 1984 was related to the coffee intake from the 1980 questionnaire, and diabetes incidence between 1984 and 1986 was related to the average coffee intake from the 1980 and 1984 questionnaires. Secondary analyses using only information from baseline questionnaires yielded similar results.
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RESULTS
The average consumption of regular coffee in the NHS decreased from 2.3 cups per day in 1980 to 1.6 cups per day in 1994. In the HPFS, the average consumption remained largely unchanged (1.4 cups per day in 1986 and 1.3 cups per day in 1994). We documented 1333 new cases of type 2 diabetes in men during 12 years of follow-up and 4085 new cases of type 2 diabetes in women during 18 years of follow-up. In both cohorts, higher coffee consumption was strongly associated with cigarette smoking and alcohol use ( Table 1) . Coffee intake was positively associated with intakes of total and saturated fats and magnesium and inversely associated with physical activity and intakes of cereal fiber, glycemic load, and tea. Coffee intake was not appreciably related to body mass index in either cohort.
After adjustment for age and body mass index, coffee consumption was associated with a statistically significantly lower risk for type 2 diabetes in both cohorts ( Table 2) . Further adjustment for physical activity, smoking, family history of diabetes, and other risk factors did not appreciably alter the results. The multivariate relative risks for diabetes according to coffee consumption categories (0, Ͻ1, 1 to 3, 4 to 5, and Ն6 cups per day) were 1.00, 0.98, 0.93, 0.71, and 0.46 (CI, 0.26 to 0.82; P ϭ 0.007 for trend), respectively, in men and 1.00, 1.16, 0.99, 0.70, and 0.71 (CI, 0.56 to 0.89; P Ͻ 0.001 for trend), respectively, in women.
We observed a modest inverse association between decaffeinated coffee consumption and incidence of type 2 diabetes in both men and women ( Table 2 ). In men, the multivariate relative risks according to consumption cate- gories (0, Ͻ1, 1 to 3, and Ն4 cups per day) were 1.00, 0.95, 0.91, and 0.74 (CI, 0.48 to 1.12; P ϭ 0.048 for trend), respectively. The corresponding relative risks for women were 1.0, 0.96, 0.88, and 0.85 (CI, 0.61 to 1.17; P ϭ 0.008 for trend), respectively. Adjustment for consumption of regular coffee did not appreciably alter these relative risks. Tea consumption was not statistically significantly associated with risk for diabetes in either cohort. We observed a statistically significant inverse association between total caffeine intake and risk for type 2 diabetes in both men and women in age-and body mass index-adjusted analyses ( Table 3) . In multivariate analyses, we further adjusted for family history of diabetes, alcohol consumption, smoking, and several dietary factors (glycemic load, trans fat, polyunsaturated fatty acids, cereal fiber, and magnesium). These statistical adjustments had little effect on the results. For men, the multivariate relative risks across quintiles of caffeine intake (0, Ͻ1, 1 to 3, 4 to 5, and Ն6 cups per day) were 1.0, 1.06, 1.01, 0.94, and 0.80 (CI, 0.66 to 0.97; P ϭ 0.002 for trend), respectively. The corresponding relative risks for women were 1.0, 1.02, 0.90, 0.85, and 0.70 (CI, 0.63 to 0.79; P Ͻ 0.001 for trend), respectively. To evaluate the effects of noncoffee sources of caffeine, we examined the association between caffeine intake and risk for type 2 diabetes among noncoffee users and observed similar inverse association in both cohorts (multivariate relative risks comparing extreme quintiles were 0.71 [CI, 0.47 to 1.06] for men and 0.67 [CI, 0.48 to 0.92] for women). To examine whether the observed inverse association between regular coffee intake and type 2 diabetes was explained by caffeine intake, we simultaneously included coffee and caffeine in 1 model. The in- verse association for both coffee and caffeine intakes was persistent, suggesting that caffeine and other components of coffee contributed to the observed inverse association. We conducted stratified analyses to evaluate whether the association between coffee consumption and type 2 diabetes varies according to body mass index, smoking, and physical activity ( Table 4 ). The inverse association was present in both lean and obese participants, although the association seemed to be stronger among obese men than lean men (P Ͼ 0.2 for interaction). Likewise, the inverse association between coffee consumption did not differ significantly between lean and obese women (P ϭ 0.28 for interaction). For both men and women, the inverse association between coffee consumption and risk for diabetes persisted in stratified analyses according to smoking status and levels of physical activity ( Table 4 ). These analyses suggest that the inverse association between coffee consumption and diabetes risk was independent of lifestyle factors.
To minimize potential bias from subclinical disease, we conducted additional analyses by excluding cases of type 2 diabetes that occurred during the first 4 years of follow-up in the cohorts. The multivariate relative risks across categories of coffee consumption (0, Ͻ1, 1 to 3, 4 to 5, and Ն6 cups per day) were 1.0, 0.94, 0.90, 0.64, and 0.34 (P ϭ 0.003 for trend), respectively, for men and 1.0, 1.14, 0.94, 0.67, and 0.73 (P Ͻ 0.001 for trend), respectively, for women. To address the possibility that surveillance varied according to coffee consumption, we performed an analysis restricted to cases reporting at least 1 symptom of diabetes at diagnosis. Results from this subgroup did not appreciably differ from those for the entire cohorts (multivariate relative risks were 1.0, 0.98, 0.93, 0.62, and 0.45 [P ϭ 0.006 for trend], respectively, for men and 1.0, 1.20, 1.02, 0.74, and 0.68 [P Ͻ 0.001 for trend], respectively, for women).
DISCUSSION
In these 2 large prospective cohorts of men and women, we found a statistically significant inverse association between coffee intake and risk for type 2 diabetes. These data are broadly consistent with a recent epidemiologic study of 17 111 Dutch men and women 30 to 60 years of age (13). Our study, however, with a much larger sample size and longer follow-up, has extended the results of the Dutch study by examining the effects of total caffeine and different types of coffee. We found a modest inverse association between higher consumption of decaffeinated coffee and diabetes risk, but no statistically significant association was observed for tea consumption.
Metabolic studies have consistently shown that acute administration of caffeine can induce insulin resistance and impair glucose tolerance (3, (5) (6) (7) (8) . One potential mechanism involves caffeine blocking the effects of adenosine A1 receptor on glucose uptake in skeletal muscle. However, more recent studies suggest that the effects of caffeine on insulin sensitivity in vivo are mediated by elevated epinephrine levels rather than by peripheral adenosine receptor antagonism because caffeine-induced glucose intolerance can be abolished by ␤-adrenergic receptor blockade with propranolol (23).
The acute adverse effects of caffeine on insulin sensitivity raise some concern that long-term coffee intake may increase risk for type 2 diabetes (8). However, complete tolerance can develop after several days of caffeine use with respect to humoral and hemodynamic variables, including blood pressure, heart rate, plasma renin activity, plasma catecholamines, or urinary catecholamines (12, 24) . Thus, the acute effects of caffeine on insulin sensitivity are probably transient and cannot be extrapolated to long-term use.
Caffeine increases basal energy expenditure; this thermogenic effect has a dose-response relationship with the amount of caffeine consumed (10), and the magnitude of thermogenesis is greater in lean women than in obese women (11). Caffeine may also stimulate fat oxidation and mobilization of glycogen in muscle (25) and stimulate free fatty acid release (increased lipolysis) from peripheral tissues (10, 26). Ingestion of caffeine, alone or with ephedrine, decreases body weight in monkeys (27) and humans (28, 29) . In our study, coffee consumption was not appreciably related to body mass index at baseline in either cohort. In addition, the inverse association between coffee and caffeine and risk for type 2 diabetes remained statistically significant after adjustment for body mass index, suggesting that the effects of coffee or caffeine are unlikely to be mediated through body weight. Coffee contains many other ingredients that may contribute to the inverse association. For example, coffee contains a substantial amount of potassium; niacin; magnesium; and antioxidant substances, such as tocopherols and phenol chlorogenic acid (30). These constituents may have beneficial effects on the development of diabetes through synergistic or independent actions on glucose metabolism and insulin resistance. This could explain a modest inverse association between consumption of decaffeinated coffee and risk for diabetes observed in our study. Dietary intake of magnesium has been associated with a lower risk for type 2 diabetes in several epidemiologic studies (21, 31) . In our study, the statistically significant inverse association for coffee persisted even after adjustment for magnesium intake. We considered the possibility that this inverse association was due to confounding by diet and lifestyle factors associated with coffee intake. Coffee consumption is frequently related to unhealthy behaviors, such as smoking, excessive consumption of alcohol, a poorer diet, and a sedentary lifestyle. The confounding effects of these variables would tend to bias the results toward a positive, not an inverse, association. In our study, we carefully controlled for these variables. Also, in stratified analyses, the inverse association between coffee intake and type 2 diabetes persisted in never and current smokers and in lean and obese participants.
Another potential concern is that persons with preexisting chronic diseases may avoid drinking coffee. However, this bias is unlikely to influence our results because we excluded participants with reported diabetes, cardiovascular disease, and cancer at baseline. Also, excluding incident diabetes cases that occurred in the first 4 years of follow-up Article Coffee and Diabetes Mellitus did not affect the results, suggesting that preclinical diabetes is unlikely to have affected our analyses. When we used light coffee drinkers as the reference group, the relative risks for moderate and high categories of coffee consumption did not substantially change. Because coffee consumption was self-reported by questionnaire, some misclassification of exposure is inevitable. However, such misclassification in prospective studies would have biased the results toward the null. Also, selfreport of coffee consumption has been extensively validated in subsamples of our cohorts. The use of repeated measures in the analyses not only accounts for changes in coffee use over time but also decreases measurement error.
In conclusion, these prospective data suggest a statistically significant inverse association between intakes of caffeine and regular coffee and incidence of diabetes in both men and women. This association is independent of body mass index, cigarette smoking, and other dietary and lifestyle factors. However, our observational study cannot prove a cause-effect relationship, and it is premature to recommend increased coffee drinking as a means to prevent type 2 diabetes. Further metabolic studies are required to investigate long-term effects of caffeine on glucose homeostasis, insulin resistance, and energy expenditure. 
